CONTI, Pio
 Distribuzione geografica
Continente #
NA - Nord America 7.529
EU - Europa 5.344
AS - Asia 5.115
SA - Sud America 564
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 7
Totale 18.633
Nazione #
US - Stati Uniti d'America 7.371
SG - Singapore 1.909
CN - Cina 1.647
UA - Ucraina 1.052
IE - Irlanda 833
GB - Regno Unito 776
TR - Turchia 773
SE - Svezia 697
BR - Brasile 485
IT - Italia 482
DE - Germania 474
FR - Francia 453
IN - India 348
FI - Finlandia 223
VN - Vietnam 204
RU - Federazione Russa 165
CA - Canada 107
AR - Argentina 46
HK - Hong Kong 43
PL - Polonia 41
KR - Corea 36
MX - Messico 34
ES - Italia 33
BE - Belgio 31
CZ - Repubblica Ceca 31
ZA - Sudafrica 26
JP - Giappone 25
BD - Bangladesh 20
IQ - Iraq 19
IL - Israele 17
IR - Iran 16
EU - Europa 14
EC - Ecuador 13
LT - Lituania 10
ID - Indonesia 9
KE - Kenya 9
RO - Romania 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 7
NL - Olanda 7
AT - Austria 6
CL - Cile 6
EG - Egitto 6
AU - Australia 5
PK - Pakistan 5
SA - Arabia Saudita 5
TN - Tunisia 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
GR - Grecia 4
MA - Marocco 4
AZ - Azerbaigian 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CO - Colombia 2
EE - Estonia 2
ET - Etiopia 2
GY - Guiana 2
IM - Isola di Man 2
JO - Giordania 2
KG - Kirghizistan 2
MD - Moldavia 2
ML - Mali 2
NZ - Nuova Zelanda 2
OM - Oman 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 18.633
Città #
Singapore 1.420
Chandler 1.130
Jacksonville 1.113
Dublin 823
Southend 531
Dallas 416
Princeton 392
Beijing 386
Izmir 372
Ashburn 371
Nanjing 321
Dearborn 227
Wilmington 223
Los Angeles 188
Cambridge 187
Santa Clara 179
Ann Arbor 168
The Dalles 155
Altamura 151
Tongling 130
Boardman 124
Nanchang 112
Buffalo 110
Munich 106
New York 106
Woodbridge 95
Ho Chi Minh City 78
Grevenbroich 73
Shenyang 73
Chieti 70
Council Bluffs 69
Houston 61
São Paulo 61
Hebei 59
Tianjin 52
Jiaxing 46
Washington 43
Hong Kong 42
Jinan 41
Kunming 40
Hanoi 39
Montréal 37
Seoul 33
Redondo Beach 32
Augusta 30
Denver 29
Warsaw 28
Brooklyn 27
Brussels 27
Hangzhou 27
Pescara 27
Brno 26
Helsinki 26
Chicago 25
Norwalk 25
Orange 25
Boston 24
Chennai 24
San Mateo 24
Turku 24
Johannesburg 23
Mcallen 23
Montreal 22
Ningbo 22
Tokyo 22
Hefei 21
Toronto 21
Zhengzhou 20
Changsha 19
London 19
Seattle 18
Auburn Hills 17
Poplar 17
Stockholm 17
Atlanta 16
Dong Ket 16
Phoenix 16
Belo Horizonte 15
Mexico City 15
Düsseldorf 14
Guangzhou 14
Hyderabad 14
Moscow 13
Taizhou 13
Pune 12
Rio de Janeiro 12
San Francisco 12
Bangalore 11
Cepagatti 11
Fairfield 11
Lanzhou 11
Leawood 11
Orem 11
Andover 10
Ankara 10
Brasília 10
Frankfurt am Main 10
Milan 10
Kocaeli 9
Mumbai 9
Totale 11.500
Nome #
Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. 237
Vascular endothelial growth factor (VEGF), mast cells and inflammation 173
Caffeine, Theophylline and bamifylline are similar as competitive inhibitors of 3' ,5'-cyclic AMP phosphodiesterase in vitro 153
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 153
Heme Oxigenase-1 (HO-1) and oxidative stress in rat heart 152
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 151
Anti-chemochine therapy for inflammatory diseases 150
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1β levels and expression in peripheral blood mononuclear cells 150
Allergen immunotherapy: an effective immune-modifier. 149
5-HT and histamine release from rat basophilic leukemia cells treated or non with IL-1RA 149
Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study 147
Augmentation of monocyte chemotactic protein-1 (MCP-1) and mRNA Transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo 145
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 143
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 141
Bamifylline similar to theophylline and caffeine is a competitive inhibitor of the cyclic nucleotide phosphodiesterase V 139
A scavenger role for nitric oxide in the aged rat kidney. 139
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 139
Microarray expression profiling of human dental pulp from single subject. 139
Nutrition and cancer prevention. 138
A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application 135
Synergistic activation of serum amyloid a (saa) by il - 6 and il - 1 in combination on human hep 3 b hepatoma cell line. Role of pge2 and il-1 receptor antagonist 132
Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related 128
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines 128
Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism 126
Interferon β1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis 126
A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy. 125
Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. 125
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 123
Effect of electromagnetic fields on several CD markers and transcription and expression of CD4 122
Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury 122
Monocyte chemotactic protein 1 (MCP-1) activates mast cells to aggregate and release [3H]-5HT 121
Activation and inhibition of adaptive immune response mediated by mast cells 121
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 120
ENOX2 (or tNOX): a new and old molecule with cancer activity involved in tumor prevention and therapy 120
Endocrinology of the skin: intradermal neuroimmune network, a new frontier 120
Chemokines as markers for parasite-induced inflammation and tumors 119
Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells. 119
ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY 119
Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37 119
IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation 118
In vitro effects of vanadate on human immune functions 117
Relevance of plant lectins in human cell biology and immunology 117
Interleukin-9 and mast cells 116
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines 116
IL-10, an inflammatory/inhibitory cytokine, but not always. 114
Calcium ionophore A23187 and compound 48/80 induce PGD2 and tryptase in human cord blood-derived mast cells: lack of effect of il-18 114
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 114
Monocyte Chemotactis Protein-1 Gene Expression and Translation in Formed Granulomatous Calcified Tissue in Vivo 114
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 114
A new diagnostic approach to better identify antiphospholipid syndrome. 113
Tridimensional response of human dental follicular stem cells onto a synthetic hydroxyapatite scaffold. 113
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 113
Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study 113
Morphostructural analysis of human follicular stem cells on highly porous bone hydroxyapatite scaffold. 113
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 113
Production of cytokines in trichinellosis infected mice 112
Interleukin-17 and the interleukin-17 family member network. 112
Effect of the compound L-mimosine in an in vivo model of chronic granuloma formation induced by potassium permanganate (KMNO4). 112
IL-36 a new member of the IL-1 family cytokines 112
L-carnitine enhances adenosine triphosphate (ATP) and inhibits lymphocite proliferation 112
The down-regulation of il-6-stimulated fibrinogen steadu state mrna and protein levels by human recombinant il-1 is not pge2-dependent:effects of il-1 receptor antagonist (il-1ra) 110
Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES. 110
Modulation of MCP-1 and iNOS by 50 Hz sinusoidal electromagnetic field 110
Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue 110
IL-32: a newly-discovered proinflammatory cytokine 110
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 108
Cytokines and allergic disorders: a revisited study 107
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 107
Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. 107
Effect of interleukin-1 receptor antagonist (IL-1RA) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells 106
Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. 106
Impact of RANTES, MCP-1 and IL-8 in mast cells 106
Interleukin-17: a revisited study. 106
Aluminum impairs rat neural cell mitochondria in vitro 105
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 105
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 104
Different effects of platinum, palladium, and rhodium salts on lymphocyte proliferation and cytokine release 104
Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2(PGE) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4 103
Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine. 103
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 102
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 102
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 102
IL-1beta induces alkaline phosphatase in human phagocytes 102
Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells 102
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 101
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 101
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 101
Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee 100
Endothelial Nitric Oxide Synthase (e-NOS)expression and localization in healthy and diabetic rat hearts 100
Infections and mast cells 100
Periodontitis and cytokine patterns in HIV positive patients 100
Transcription and translation of the chemokines RANTES and MCP-1 in nasal polyps and mucosa in allergic and non-allergic rhinopathies 100
Substance P upregulates LTB4 in rat adherent macrophages from granuloma induced by KMnO4 99
Irritable bowel syndrome and bronchial hyperresponsiveness: is there a link? 98
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 98
Inhibition of P-glycoprotein mediated transport by S-adenosylmethionine and Cynarin in multidrug resistant human uterine sarcoma MES-SA/Dx5 cells. 98
Will MCP-1 and RANTES take center stage in inflammatory diseases including asthma? 97
Vitamin B6-deficient diet plus 4-deoxypyridoxine (4-DPD) reduces the inflammatory response induced by T. spiralis in diaphragm, masseter and heart muscle tissue of mice 97
IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells. 97
Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects. 97
Totale 11.870
Categoria #
all - tutte 74.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021798 0 0 0 0 0 283 28 5 154 183 60 85
2021/2022789 28 13 4 166 64 3 16 64 54 26 104 247
2022/20232.982 258 380 181 360 328 587 162 194 373 34 62 63
2023/20241.135 95 40 66 38 63 314 313 37 19 21 13 116
2024/20253.225 234 596 579 59 69 89 47 148 281 139 364 620
2025/20263.175 539 312 752 736 568 268 0 0 0 0 0 0
Totale 19.159